GLP-1 RAs can also be classified on the basis of structure, duration of action and mode of delivery, as shown in Table 1 [13]
The potential side effects of semaglutide and tirzepatide, even in FDA-approved formulations, include nausea, constipation, and, in rare cases, more serious issues like pancreatitis and kidney problems
The drug demonstrated statistically significant improvements in both primary endpoints of the study for patients with heart failure with preserved ejection fraction (HFpEF) and obesity
This biochemical intervention helps reset the patients relationship with food, making the transition to a healthier lifestyle feel more manageable and less like an uphill battle
Pull back the plunger past your dose amount
This program is built on principles extracted from clinical trials examining body composition during GLP-1 therapy, combined with established strength training science